• Citer

Phase II trial with brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: A study of the early clinical trials group of the EORTC

par Dodion, Pierre ;Wagener, Theo;Stoter, Gerrit;Drozdzecki, Andrzej;Lev, Louise L.M.;Skovsgaard, Torben;Renard, Josette;Cavalli, Franco
Référence Annals of oncology, 1, 1, page (79-80)
Publication Publié, 1990

Article révisé par les pairs

• Détails

Titre:	Phase II trial with brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: A study of the early clinical trials group of the EORTC
Auteur:	Dodion, Pierre; Wagener, Theo; Stoter, Gerrit; Drozdzecki, Andrzej; Lev, Louise L.M.; Skovsgaard, Torben; Renard, Josette; Cavalli, Franco
Informations sur la publication:	Annals of oncology, 1, 1, page (79-80)
Statut de publication:	Publié, 1990
Sujet CREF:	Hématologie
	Cancérologie
Mots-clés:	Brequinar
	Colorectal cancer
	Phase II
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:scp/0025157969
	info:pmid/2078489